Latest news
MannKind Bets On Furoscix And Higher-Margin ReadyFlow - FinimizeFinimize · Thu, 06 Aug 2026 18:20:09 GMTNewly Approved IV-Equivalent Autoinjector Offers Fast, At-Home Edema Treatment for HF, CKD Patients - MedscapeMedscape · Tue, 04 Aug 2026 09:48:49 GMTWeekly Recap: MannKind (MNKD) Furoscix FDA clearance and Aug 5 Q2 call - TradingViewTradingView · Mon, 03 Aug 2026 11:33:16 GMTWhy MannKind (MNKD) Is Down 5.3% After Dual Lung And Heart Failure Milestones And What's Next - webull.comwebull.com · Sun, 02 Aug 2026 01:20:38 GMTMannKind Corporation (MNKD) Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload - Slideshow (NASDAQ:MNKD) 2026-07-31 - Seeking AlphaSeeking Alpha · Fri, 31 Jul 2026 07:00:00 GMTFuroscix ReadyFlow (Furosemide) and its Impact on HF, CKD Edema Treatment - HCPLiveHCPLive · Tue, 28 Jul 2026 07:00:00 GMTFDA approves at-home Furoscix ReadyFlow autoinjector - McKnight's Senior LivingMcKnight's Senior Living · Tue, 28 Jul 2026 07:00:00 GMT